Unknown

Dataset Information

0

Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT.


ABSTRACT: Patients with acute leukemia who are unable to achieve complete remission prior to allogeneic hematopoietic stem cell transplantation (SCT) have dismal outcomes, with relapse rates well in excess of 60%. Haplo-identical SCT (haplo-SCT) may allow enhanced graft-versus-leukemia (GVL) effects by virtue of HLA class I/II donor-host disparities, but it typically requires intensive immunosuppression with posttransplant cyclophosphamide (PT-Cy) to prevent lethal graft-versus-host disease (GVHD). Here, we demonstrate in preclinical models that glucocorticoid administration from days -1 to +5 inhibits alloantigen presentation by professional recipient antigen presenting cells in the gastrointestinal tract and prevents donor T cell priming and subsequent expansion therein. In contrast, direct glucocorticoid signaling of donor T cells promotes chemokine and integrin signatures permissive of preferential circulation and migration into the BM, promoting donor T cell residency. This results in significant reductions in GVHD while promoting potent GVL effects; relapse in recipients receiving glucocorticoids, vehicle, or PT-Cy was 12%, 56%, and 100%, respectively. Intriguingly, patients with acute myeloid leukemia not in remission who received unmanipulated haplo-SCT and peritransplant glucocorticoids also had an unexpectedly low relapse rate at 1 year (32%; 95% CI, 18%-47%) with high overall survival at 3 years (58%; 95% CI, 38%-74%). These data highlight a potentially simple and effective approach to prevent relapse in patients with otherwise incurable leukemia that could be studied in prospective randomized trials.

SUBMITTER: Inoue T 

PROVIDER: S-EPMC8663779 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-10-31 | GSE184963 | GEO
| PRJNA767106 | ENA
| S-EPMC6063510 | biostudies-literature
| 2008483 | ecrin-mdr-crc
| S-EPMC3140222 | biostudies-literature
| S-EPMC3507140 | biostudies-literature
| S-EPMC6483874 | biostudies-literature
| S-EPMC5977987 | biostudies-literature
| S-EPMC4131885 | biostudies-literature
| S-EPMC8268935 | biostudies-literature